Article By:
KKD Healthcare Analytics
Friday, June 23, 2017 9:31 AM EDT
DelMar Pharmaceuticals announced that it has received Institutional Review Board approval to conduct a Phase 3 clinical trial. Pfizer received a setback from the FDA. Roche announced receiving the FDA approval .
In this article: PFE, RHHBY, TROV, QGEN, DMPI, IONS, VTGN, PRTO
Read
Article By:
Marc Chandler
Friday, June 23, 2017 9:10 AM EDT
Japan's Ministry of Finance reports portfolio flows on a week weekly basis. It provide more timely, even if less detailed information than contained in the monthly balance of payments data.
In this article: FXY, UUP
Read
Article By:
Sid Thapar
Friday, June 23, 2017 9:03 AM EDT
Bank Nifty has started showing weakness after it was in an all-time high.
Read
Article By:
Elliottwave Forecast
Friday, June 23, 2017 8:54 AM EDT
DJI Index is expected to end short-term wave 4 pullback from 6/19 peak at 21257 – 21221, then it should resume the rally higher.
In this article: DJI Also: DIA
Read
Article By:
Phil Flynn
Friday, June 23, 2017 8:49 AM EDT
Downgrades across the energy sector raises real questions about the ability of shale producer to operate with prices in the low $40s.
In this article: OIL, UCO, USO
Read
Internet retail is indeed gaining market share from brick-and-mortar retailers, but plenty of retailers with a physical presence will survive the e-commerce onslaught.
Inflation isn’t dead, and neither is this myth. It will come back again in a few years – I am sure of it.
Forecasting economic activity is generally a thankless task — unless you’re using demographics as a modeling foundation, which provides a surprisingly accurate means for looking ahead.
USD/JPY is still in the corrective phase after tracing out 5 waves up from lows.
Metals and Miners showed subtle signs of bouncing. Gold and Silver still need to secure closes above their 10-day EMA’s to confirm a bounce.
Central banks no longer command the attention of investor sovereign bond markets.
